This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barker, J. H.
Right arrow Articles by Nauseef, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barker, J. H.
Right arrow Articles by Nauseef, W. M.

 Previous Article  |  Next Article 

Infection and Immunity, June 2006, p. 3277-3284, Vol. 74, No. 6
0019-9567/06/$08.00+0     doi:10.1128/IAI.02011-05

Basis for the Failure of Francisella tularensis Lipopolysaccharide To Prime Human Polymorphonuclear Leukocytes

Jason H. Barker,1 Jerrold Weiss,1,2 Michael A. Apicella,1,2 and William M. Nauseef1,2*

Inflammation Program and Department of Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa and Veterans Administration Medical Center,1 Department of Microbiology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa2

Received 14 December 2005/ Returned for modification 23 January 2006/ Accepted 27 February 2006

Francisella tularensis is the intracellular gram-negative coccobacillus that causes tularemia, and its virulence and infectiousness make it a potential agent of bioterrorism. Previous studies using mononuclear leukocytes have shown that the lipopolysaccharide (LPS) of F. tularensis is neither a typical proinflammatory endotoxin nor an endotoxin antagonist. This inertness suggests that F. tularensis LPS does not bind host LPS-sensing molecules such as LPS-binding protein (LBP). Using priming of the polymorphonuclear leukocyte (PMN) oxidase as a measure of endotoxicity, we found that F. tularensis live vaccine strain LPS did not behave like either a classic endotoxin or an endotoxin antagonist in human PMNs, even when the concentration of LBP was limiting. Furthermore, F. tularensis LPS did not compete with a radiolabeled lipooligosaccharide from Neisseria meningitidis for binding to LBP or to the closely related PMN granule protein, bactericidal/permeability-increasing protein. Our results suggest that the inertness of F. tularensis LPS and the resistance of F. tularensis to oxygen-independent PMN killing may result from the inability of F. tularensis LPS to be recognized by these important LPS-sensing molecules of the innate immune system.


* Corresponding author. Mailing address: Inflammation Program and Department of Medicine, University of Iowa, D160 MTF, 2501 Crosspark Road, Coralville, IA, 52241. Phone: (319) 335-4278. Fax: (319) 335-4194. E-mail: william-nauseef{at}uiowa.edu.

Editor: J. T. Barbieri


Infection and Immunity, June 2006, p. 3277-3284, Vol. 74, No. 6
0019-9567/06/$08.00+0     doi:10.1128/IAI.02011-05




This article has been cited by other articles:

  • Savitt, A. G., Mena-Taboada, P., Monsalve, G., Benach, J. L. (2009). Francisella tularensis Infection-Derived Monoclonal Antibodies Provide Detection, Protection, and Therapy. CVI 16: 414-422 [Abstract] [Full Text]  
  • Huntley, J. F., Conley, P. G., Rasko, D. A., Hagman, K. E., Apicella, M. A., Norgard, M. V. (2008). Native Outer Membrane Proteins Protect Mice against Pulmonary Challenge with Virulent Type A Francisella tularensis. Infect. Immun. 76: 3664-3671 [Abstract] [Full Text]  
  • Oyston, P. C. F. (2008). Francisella tularensis: unravelling the secrets of an intracellular pathogen. J Med Microbiol 57: 921-930 [Abstract] [Full Text]  
  • Lembo, A., Pelletier, M., Iyer, R., Timko, M., Dudda, J. C., West, T. E., Wilson, C. B., Hajjar, A. M., Skerrett, S. J. (2008). Administration of a Synthetic TLR4 Agonist Protects Mice from Pneumonic Tularemia. J. Immunol. 180: 7574-7581 [Abstract] [Full Text]  
  • McLendon, M. K., Schilling, B., Hunt, J. R., Apicella, M. A., Gibson, B. W. (2007). Identification of LpxL, a Late Acyltransferase of Francisella tularensis. Infect. Immun. 75: 5518-5531 [Abstract] [Full Text]  
  • Gallagher, L. A., Ramage, E., Jacobs, M. A., Kaul, R., Brittnacher, M., Manoil, C. (2007). A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate. Proc. Natl. Acad. Sci. USA 104: 1009-1014 [Abstract] [Full Text]  
  • Malik, M., Bakshi, C. S., McCabe, K., Catlett, S. V., Shah, A., Singh, R., Jackson, P. L., Gaggar, A., Metzger, D. W., Melendez, J. A., Blalock, J. E., Sellati, T. J. (2007). Matrix Metalloproteinase 9 Activity Enhances Host Susceptibility to Pulmonary Infection with Type A and B Strains of Francisella tularensis. J. Immunol. 178: 1013-1020 [Abstract] [Full Text]  
  • Hajjar, A. M., Harvey, M. D., Shaffer, S. A., Goodlett, D. R., Sjostedt, A., Edebro, H., Forsman, M., Bystrom, M., Pelletier, M., Wilson, C. B., Miller, S. I., Skerrett, S. J., Ernst, R. K. (2006). Lack of In Vitro and In Vivo Recognition of Francisella tularensis Subspecies Lipopolysaccharide by Toll-Like Receptors. Infect. Immun. 74: 6730-6738 [Abstract] [Full Text]